share_log

United States Cellular Analyst Ratings

Benzinga ·  Jul 26, 2023 23:26
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/26/2023 46.18% Morgan Stanley $26 → $27 Maintains Equal-Weight
07/25/2023 46.18% Morgan Stanley $26 → $27 Maintains Equal-Weight
05/08/2023 -13.37% Wells Fargo $22 → $16 Maintains Underweight
02/07/2023 29.94% Morgan Stanley $37 → $24 Maintains Equal-Weight
01/10/2023 8.28% Wells Fargo $33 → $20 Downgrades Overweight → Underweight
11/08/2022 29.94% JP Morgan $32 → $24 Upgrades Underweight → Neutral
11/07/2022 Raymond James Downgrades Strong Buy → Market Perform
08/08/2022 111.15% Raymond James $41 → $39 Maintains Strong Buy
05/09/2022 121.98% Raymond James $40 → $41 Maintains Strong Buy
04/19/2022 100.32% Morgan Stanley → $37 Downgrades Overweight → Equal-Weight
02/22/2022 78.67% Wells Fargo $36 → $33 Maintains Overweight
02/22/2022 116.57% Raymond James $43 → $40 Maintains Strong Buy
08/02/2021 94.91% JP Morgan $35 → $36 Downgrades Neutral → Underweight
07/22/2021 170.71% Morgan Stanley $50.5 → $50 Maintains Overweight
02/22/2021 89.5% JP Morgan $42 → $35 Downgrades Overweight → Neutral
01/14/2021 173.42% Morgan Stanley $57 → $50.5 Maintains Overweight
11/16/2020 94.91% Wells Fargo → $36 Reinstates → Overweight
08/31/2020 149.05% Citigroup $45 → $46 Maintains Buy
08/27/2020 208.61% Morgan Stanley $56 → $57 Maintains Overweight
08/10/2020 132.81% Raymond James $40 → $43 Maintains Strong Buy
07/08/2020 203.19% Morgan Stanley $57 → $56 Maintains Overweight
05/18/2020 116.57% Raymond James $39 → $40 Reiterates → Strong Buy
05/14/2020 84.08% B. Riley Securities $42 → $34 Maintains Neutral
04/22/2020 111.15% Raymond James $41 → $39 Maintains Strong Buy
04/09/2020 208.61% Morgan Stanley $63 → $57 Maintains Overweight
03/27/2020 127.4% JP Morgan $45 → $42 Maintains Overweight
03/02/2020 241.09% Citigroup $66 → $63 Maintains Buy
11/04/2019 165.3% Raymond James $53 → $49 Upgrades Outperform → Strong Buy
11/04/2019 143.64% JP Morgan → $45 Upgrades Neutral → Overweight
08/06/2019 116.57% Wells Fargo $50 → $40 Maintains Market Perform
08/06/2019 127.4% B. Riley Securities $50 → $42 Maintains Neutral
08/05/2019 149.05% JP Morgan → $46 Upgrades Underweight → Neutral
06/18/2019 249.21% Morgan Stanley $44 → $64.5 Upgrades Equal-Weight → Overweight
05/06/2019 186.95% Raymond James $56 → $53 Reiterates → Outperform
11/06/2018 203.19% Raymond James $43 → $56 Maintains Outperform
08/08/2018 176.12% Citigroup $49 → $51 Maintains Buy

What is the target price for United States Cellular (USM)?

The latest price target for United States Cellular (NYSE: USM) was reported by Morgan Stanley on July 26, 2023. The analyst firm set a price target for $27.00 expecting USM to rise to within 12 months (a possible 46.18% upside). 8 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for United States Cellular (USM)?

The latest analyst rating for United States Cellular (NYSE: USM) was provided by Morgan Stanley, and United States Cellular maintained their equal-weight rating.

When is the next analyst rating going to be posted or updated for United States Cellular (USM)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of United States Cellular, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for United States Cellular was filed on July 26, 2023 so you should expect the next rating to be made available sometime around July 26, 2024.

Is the Analyst Rating United States Cellular (USM) correct?

While ratings are subjective and will change, the latest United States Cellular (USM) rating was a maintained with a price target of $26.00 to $27.00. The current price United States Cellular (USM) is trading at is $18.47, which is out of the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment